Abstract library

6 results for "Adamo".
#1024 Minimally Invasive Surgery for Pancreatic Neuroendocrine Tumors: Why Not?
Introduction: Recent evidence suggests that pancreatic neuroendocrine tumors (pNETs) are amenable to minimally invasive resections (MIPR).
Conference: 11th Annual ENETS Conference (2014)
Category: Surgical treatment
Presenting Author: doctor Anna Malpaga
#1832 Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results for a Single Institutional Surgical Series
Introduction: Cystic pancreatic neuroendocrine tumors (CPanNET) are an uncommon variant of pancreatic neuroendocrine tumors (PanNETs). Due to their rarity, there is a lack of knowledge with regards to clinical features and prognosis.
Conference: 14th Annual ENETS conference (2017)
Category: Surgical treatment
Presenting Author: MD Marco Miotto
Keywords: cystic
#1839 Laparoscopic and Robotic Resection for Pancreatic Neuroendocrine Tumors (pNET): Less Is More?
Introduction: Laparoscopy is useful for the resection of pNET, but only a few studies in the Literature describes outcomes for a large series
Conference: 14th Annual ENETS conference (2017)
Category: Surgical treatment
Presenting Author: DOCTOR Isacco Damoli
#1902 18F-FDG Positron Emission Tomography/Computed Tomography Positivity in Small Incidentally-Found Pancreatic Neuroendocrine Tumors: Could It Be Considered a Predictor of Malignancy?
Introduction: Surgical management of small (<2 cm), incidentally found sporadic non functioning pancreatic neuroendocrine tumors (NF-PanNETs) is controversial. Normal practice in our Institution is to observe them when asymptomatic, without worrying features at imaging and without uptake at F-PET/CT.
Conference: 14th Annual ENETS conference (2017)
Category: Surgical treatment
Presenting Author: Doctor Anna Malpaga
#2151 Therapeutic Efficacy of Platinum/Etoposide Regimens in the Treatment of Advanced Poor Differentiated Neuroendocrine Carcinomas of the Lung: A Retrospective Analysis
Introduction: Advanced neuroendocrine carcinomas (NEC) of the lung are associated with a dismal prognosis and are commonly treated with platinum/etoposide (P/E) regimens. However, few studies evaluated their impact in lung NEC and it is still unclear whether the outcome of such patients (pts) has been improved over the past years (yrs).
Conference: 15th Annual ENETS conference (2018)
Category: Medical treatment - Chemotherapy Somatostatin analogues, Interferon
Presenting Author: Professor Vincenzo Adamo
#2228 Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Non Functioning Pancreatic Neuroendocrine Tumors: Outcome Analysis from 378 Consecutive Resections in a High-Volume Institution
Introduction: The optimal management of regional lymph nodes during resections of Pancreatic Neuroendocrine Tumors (pNETs) remains controversial. Conflicting data exist on predictors of LN metastases (LNM) and their impact on survival
Conference: 15th Annual ENETS conference (2018)
Category: Surgical treatment and Ablative Therapies
Presenting Author: doctor Anna Malpaga
Authors: Malpaga A, Miotto M, Elio G, Nessi C, ...
Close
Notice

WARNING – FRAUDULENT WEBSITES

ENETS is aware that its members have been confronted with fake websites, which seem to relate to our congress but have not been commissioned or authorised by us. The websites offer fraudulent hotel reservation services. We therefore strongly recommend that you please only use the official enetsconference.org website when booking your tickets and accommodation. Please be vigilant when it comes to providing your credit card details. 

If you have any questions, please do not hesitate to contact us at info@enets.org.